BG24815A3 - Metod za poluczavane na zamesteni purini - Google Patents

Metod za poluczavane na zamesteni purini

Info

Publication number
BG24815A3
BG24815A3 BG7500032819A BG3281975A BG24815A3 BG 24815 A3 BG24815 A3 BG 24815A3 BG 7500032819 A BG7500032819 A BG 7500032819A BG 3281975 A BG3281975 A BG 3281975A BG 24815 A3 BG24815 A3 BG 24815A3
Authority
BG
Bulgaria
Prior art keywords
substituted purines
obtaining substituted
obtaining
purines
substituted
Prior art date
Application number
BG7500032819A
Other languages
English (en)
Inventor
Shaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10402412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG24815(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BG24815A3 publication Critical patent/BG24815A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
BG7500032819A 1974-09-02 1975-09-02 Metod za poluczavane na zamesteni purini BG24815A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38278/74A GB1523865A (en) 1974-09-02 1974-09-02 Purine compunds and salts thereof

Publications (1)

Publication Number Publication Date
BG24815A3 true BG24815A3 (bg) 1978-05-12

Family

ID=10402412

Family Applications (4)

Application Number Title Priority Date Filing Date
BG7530910A BG26389A3 (bg) 1974-09-02 1975-09-02
BG7500032819A BG24815A3 (bg) 1974-09-02 1975-09-02 Metod za poluczavane na zamesteni purini
BG7532817A BG26536A4 (bg) 1974-09-02 1975-09-02
BG7500032818A BG25094A3 (bg) 1974-09-02 1975-09-02 Metod za poluczavane na substituirani purini

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG7530910A BG26389A3 (bg) 1974-09-02 1975-09-02

Family Applications After (2)

Application Number Title Priority Date Filing Date
BG7532817A BG26536A4 (bg) 1974-09-02 1975-09-02
BG7500032818A BG25094A3 (bg) 1974-09-02 1975-09-02 Metod za poluczavane na substituirani purini

Country Status (35)

Country Link
US (3) US4294831A (bg)
JP (1) JPS5154589A (bg)
AR (4) AR220299A1 (bg)
AT (1) AT354462B (bg)
AU (1) AU503160B2 (bg)
BE (1) BE833006A (bg)
BG (4) BG26389A3 (bg)
CA (1) CA1062257A (bg)
CH (7) CH626363A5 (bg)
CS (2) CS203092B2 (bg)
CY (1) CY1033A (bg)
DD (1) DD122092A5 (bg)
DE (1) DE2539963A1 (bg)
DK (1) DK146595C (bg)
ES (3) ES440631A1 (bg)
FI (1) FI60709C (bg)
FR (1) FR2282892A1 (bg)
GB (1) GB1523865A (bg)
HK (1) HK84379A (bg)
HU (1) HU176730B (bg)
IE (1) IE42282B1 (bg)
IL (1) IL48035A (bg)
KE (1) KE3002A (bg)
LU (1) LU73304A1 (bg)
MC (1) MC1068A1 (bg)
MY (1) MY8200191A (bg)
NL (1) NL175061C (bg)
NO (1) NO144216C (bg)
NZ (1) NZ178556A (bg)
RO (4) RO74275A (bg)
SE (1) SE428562C (bg)
SU (7) SU904523A3 (bg)
YU (4) YU39947B (bg)
ZA (1) ZA755574B (bg)
ZM (1) ZM12875A1 (bg)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4287188A (en) 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
AU521577B2 (en) * 1977-02-24 1982-04-22 Wellcome Foundation Limited, The 9-hydroxyethoxymethyl guanine phosphates
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
AU547311B2 (en) * 1980-10-15 1985-10-17 Wellcome Foundation Limited, The Treating viral infections in fish
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4603219A (en) * 1981-05-21 1986-07-29 Syntex (U.S.A.) Inc. 1,3-dibenzyloxy-2-acetoxymethoxypropane, intermediate for 9-(1,3-dihydroxy-2-propoxymethyl)guanine
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
EP0072027B1 (en) * 1981-08-11 1988-05-18 The Wellcome Foundation Limited Antiviral compounds
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
JPS59500317A (ja) * 1982-02-12 1984-03-01 シンテツクス　（ユー・エス・エイ）　インコーポレイテツド 抗ウイルス性組成物
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
US4745119A (en) * 1982-10-14 1988-05-17 Burroughs Wellcome Co. Method for using purine derivatives
FI74468C (fi) * 1982-10-14 1988-02-08 Wellcome Found Foerfarande foer framstaellning av terapeutiskt aktiva 2-aminopurinderivat.
US5059604A (en) * 1982-10-14 1991-10-22 Burroughs Wellcome Co. 2-amino purine derivatives
US4649140A (en) * 1982-10-14 1987-03-10 Burroughs Wellcome Co. Purine derivatives
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
ES520140A0 (es) * 1983-02-25 1984-04-01 Ind Farma Especial Un procedimiento para la preparacion de acicloguanosina.
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
JPS6023380A (ja) * 1983-06-24 1985-02-05 メルク・エンド・カムパニー・インコーポレーテッド 抗ウイルス剤
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
ZA848080B (en) * 1983-10-31 1985-06-26 Warner Lambert Co Purine derivatives
US4918219A (en) * 1983-10-31 1990-04-17 Warner-Lambert Company Glycerine derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
IL74881A0 (en) * 1984-04-13 1985-07-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3585643D1 (de) 1984-07-03 1992-04-23 Wellcome Found Antiviren-verbindungen, behandlung und formulierungen.
EP0190123A1 (en) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulatory and anti-viral compound
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US5683990A (en) * 1985-03-16 1997-11-04 Glaxo Wellcome Inc. Treatment of human viral infections
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
DE3667058D1 (en) 1985-05-02 1989-12-28 Wellcome Found Antiviral compounds
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
AU618723B2 (en) * 1986-10-06 1992-01-09 University Of Virginia Alumni Patents Foundation, The Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
JPH01501478A (ja) * 1986-11-25 1989-05-25 インスティテュト　オルガニチェスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスアール ９―置換グアニン
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US4835104A (en) * 1987-06-16 1989-05-30 Ajinomoto Co., Inc., Patent & Licensing Department Process for producing and purifying 2',3'-dideoxynucleosides, and process for producing 2',3'-dideoxy-2',3'-didehydronucleosides
US6306647B1 (en) 1987-06-16 2001-10-23 Ajinomoto Co., Inc. Process for producing and purifying 2′,3′-dideoxynucleosides, and process for producing 2′,3′-dideoxy-2′,3′-didehydronucleosides
GB8725939D0 (en) * 1987-11-05 1987-12-09 Wellcome Found Therapeutic compounds
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
CA1302887C (en) * 1987-11-24 1992-06-09 Yves Langelier Combination of acyclovir or a derivative thereof and bacitracin
JPH01121424U (bg) * 1988-02-10 1989-08-17
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
DE68907013D1 (de) * 1988-10-24 1993-07-15 Wellcome Found Guaninderivate mit antiviraler wirkung und deren pharmazeutisch vertraegliche salze.
AU626983B2 (en) * 1989-01-31 1992-08-13 Whitby Research, Inc. N6-substituted 9-methyladenines
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
GB8907173D0 (en) * 1989-03-30 1989-05-10 Beecham Group Plc Novel compounds
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
DK169121B1 (da) 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
EP0589335B1 (de) * 1992-09-24 2003-06-18 Hoechst Aktiengesellschaft N1-Substituierte 1H-1,2,3-Triazolo[4,5-d]pyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
IT1264599B1 (it) * 1993-06-14 1996-10-04 Solar Chem Sa Processo per la sintesi della 9-(2-idrossietossimetil)- guanina
US5567816A (en) * 1994-07-26 1996-10-22 Syntex (U.S.A.) Inc. Preparation of acyclovir using 1,3 dioxolane
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
IN179493B (bg) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
US5789589A (en) * 1996-04-22 1998-08-04 Drug Innovation & Design, Inc. Guanine analog phosphates
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6180790B1 (en) 1997-05-15 2001-01-30 Drug Innovation And Design, Inc. Methods of preparing acyclovir prodrugs
AU731225C (en) 1997-05-15 2001-10-18 Drug Innovation & Design, Inc. Acyclovir diester derivatives
YU31104A (sh) * 2001-10-16 2006-08-17 Avanir Pharmaceuticals Inhibicija virusa n-dokozanolom
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
JP4397691B2 (ja) * 2001-10-30 2010-01-13 コンフォーマ・セラピューティクス・コーポレイション Ｈｓｐ９０阻害活性を有するプリン類似体
US7078524B2 (en) 2002-11-22 2006-07-18 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
EP3025718A1 (en) 2003-01-14 2016-06-01 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
US20040200730A1 (en) * 2003-04-14 2004-10-14 Kyo Jibiki Hydrometallurgical copper recovery process
MXPA06013295A (es) 2004-05-19 2007-02-22 Emisphere Tech Inc Formulaciones de aciclovir.
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
US20090203636A1 (en) * 2006-03-14 2009-08-13 Bondarev Igor E Prevention and Treatment of Cancer and Other Diseases
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
JP5793084B2 (ja) 2008-12-23 2015-10-14 ギリアド ファーマセット エルエルシー プリンヌクレオシドの合成
BRPI0922508A8 (pt) 2008-12-23 2016-01-19 Pharmasset Inc Análogos de nucleosídeo
CN102858790A (zh) 2010-03-31 2013-01-02 吉利德制药有限责任公司 核苷氨基磷酸酯
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines

Also Published As

Publication number Publication date
DE2539963C2 (bg) 1987-01-22
CH628897A5 (de) 1982-03-31
US4294831A (en) 1981-10-13
KE3002A (en) 1979-12-14
MY8200191A (en) 1982-12-31
FR2282892B1 (bg) 1980-04-25
BG26389A3 (bg) 1979-03-15
BG26536A4 (bg) 1979-04-12
CH629805A5 (de) 1982-05-14
NO144216B (no) 1981-04-06
CH629206A5 (de) 1982-04-15
RO74276A (ro) 1981-06-26
SE7509675L (sv) 1976-03-03
YU39947B (en) 1985-06-30
SU686618A3 (ru) 1979-09-15
SE428562C (sv) 1985-08-20
IL48035A (en) 1981-07-31
NO144216C (no) 1981-07-15
ES440631A1 (es) 1977-06-16
NL175061B (nl) 1984-04-16
FI60709B (fi) 1981-11-30
US4360522A (en) 1982-11-23
NL7510342A (nl) 1976-03-04
SU751325A3 (ru) 1980-07-23
SU904523A3 (ru) 1982-02-07
YU40080B (en) 1985-06-30
AR212914A1 (es) 1978-11-15
SU858569A3 (ru) 1981-08-23
AU8445975A (en) 1977-03-10
CH626363A5 (bg) 1981-11-13
NZ178556A (en) 1978-09-25
AR220508A1 (es) 1980-11-14
DK146595B (da) 1983-11-14
SU784777A3 (ru) 1980-11-30
SE428562B (sv) 1983-07-11
ES455978A1 (es) 1978-01-16
AT354462B (de) 1979-01-10
DK392675A (da) 1976-03-03
LU73304A1 (bg) 1976-08-13
ES455979A1 (es) 1978-01-16
FI752465A (bg) 1976-03-03
SU700064A3 (ru) 1979-11-25
YU120182A (en) 1982-08-31
ZA755574B (en) 1977-04-27
IL48035A0 (en) 1975-11-25
IE42282L (en) 1976-03-02
JPS6147839B2 (bg) 1986-10-21
CH623587A5 (bg) 1981-06-15
RO74275A (ro) 1981-09-24
HK84379A (en) 1979-12-14
CH623586A5 (bg) 1981-06-15
ATA676375A (de) 1979-06-15
MC1068A1 (fr) 1976-05-21
GB1523865A (en) 1978-09-06
SU799664A3 (ru) 1981-01-23
IE42282B1 (en) 1980-07-16
CY1033A (en) 1980-08-01
NO753009L (bg) 1976-03-03
DE2539963A1 (de) 1976-03-18
CS203092B2 (en) 1981-02-27
YU120082A (en) 1982-08-31
FR2282892A1 (fr) 1976-03-26
CH626364A5 (bg) 1981-11-13
AU503160B2 (en) 1979-08-23
HU176730B (en) 1981-04-28
CA1062257A (en) 1979-09-11
JPS5154589A (en) 1976-05-13
DD122092A5 (bg) 1976-09-12
AR220885A1 (es) 1980-12-15
AR220299A1 (es) 1980-10-31
RO76939A (ro) 1981-06-22
BE833006A (fr) 1976-03-02
CS203093B2 (en) 1981-02-27
NL175061C (nl) 1984-09-17
YU222075A (en) 1982-08-31
DK146595C (da) 1984-04-24
RO74274A (ro) 1981-09-24
YU40079B (en) 1985-06-30
BG25094A3 (bg) 1978-07-12
US4323573A (en) 1982-04-06
ZM12875A1 (en) 1977-09-21
FI60709C (fi) 1982-03-10
YU119982A (en) 1982-08-31

Similar Documents

Publication Publication Date Title
BG24815A3 (bg) Metod za poluczavane na zamesteni purini
BG27553A3 (bg) Metod za poluchavane na 2- fenil- 3- aroilbenzotiofeni
BG27744A3 (bg) Metod za poluchavane na khinazolinovi proizvodni
BG24812A3 (bg) Metod za poluczavane na 8-tiometilergolini
BG27548A3 (bg) Metod za poluchavane na karbonilskbstituirani 1- sulfonilbenzimidazoli
BG31949A3 (bg) Metod za poluchavane na proizvodni na femil- 2- indol
BG31223A3 (bg) Metod za poluchavane na tretichni olefini
BG27374A3 (bg) Metod za poluchavane na s"edinenija s ergolinova struktura
BG24542A3 (bg) Metod za poluczavane na karbonilaldiminometanfosfonati
BG27542A3 (bg) Metod za poluchavane na 1- benzazolilalkil = zamestini piperidini
CS191882B2 (en) Method of preparing 7-methoxy-6-thia-tetracycline
BG24799A3 (bg) Metod za poluczavana na benzoilureido-difenileteri
BG27355A3 (bg) Metod za poluchavane na 11- dezoksi- 16-ariloksi-w- tetranorprostaglandini
BG24807A3 (bg) Metod za poluczavane na piridobenzodiazepinoni
BG29427A3 (bg) Metod za poluchavane nal-6- deoksi-5- khidroksitetraciklin
BG27915A3 (en) Method of obtaining of moenomyzin
BG27899A3 (en) Method of obtaining of highdispersed cianurchloride
BG27543A3 (bg) Metod za poluchavane na n- aril- n- (1- l- 4- piperidinil)- arilacetamidi
BG24801A3 (bg) Metod za poluczavane na l-piroglutamil-l-prolinamid
BG33287A3 (en) Method for obtaining of 6- methyl- 8- (substituated) methylergolin
BG31503A3 (bg) Metod za poluchavane na proizvodni na oktakhidroindolkhinolizina
CS182298B2 (en) Method of producing substituted benzendisulphon-amides
BG27753A3 (bg) Metod za poluchavane na 7- amino- 3- h1- karboksimetiltetrazol- 5- il- tiometil)- 3- cefem- 4- karbonova kiselina
BG30776A3 (bg) Metod za poluchavane na eburnameninovi proizvodni
BG27732A3 (bg) Metod za poluchavane na dizamesteni fenoleteri na 3- amino- 2- khidroksipropan